Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lam Research | LRCX | Feb 28, 2025 | 76.74 | +0.75 |
Lamar Advertising A | LAMR | Feb 28, 2025 | 124.23 | +1.69 |
Lamb Weston | LW | Feb 28, 2025 | 51.87 | +0.76 |
Lancaster Colony | LANC | Feb 28, 2025 | 191.16 | +0.59 |
Landbridge Company | LB | Feb 28, 2025 | 69.18 | +6.61 |
Landmark Bancorp | LARK | Feb 28, 2025 | 24.15 | +0.37 |
Lands End | LE | Feb 28, 2025 | 11.78 | +1.46 |
Landsea Homes | LSEA | Feb 28, 2025 | 7.12 | +8.37 |
Landstar System | LSTR | Feb 28, 2025 | 158.80 | +1.75 |
Lantern Pharma | LTRN | Feb 28, 2025 | 3.95 | -1.00 |
Lantheus | LNTH | Feb 28, 2025 | 93.82 | +2.55 |
Lantronix | LTRX | Feb 28, 2025 | 2.56 | -1.54 |
Lanvin Group | LANV | Feb 28, 2025 | 1.98 | +4.76 |
Lanzatech Global | LNZA | Feb 28, 2025 | 0.80 | +6.55 |
Largecap Core Alphadex First Trust | FEX | Feb 28, 2025 | 107.06 | +1.53 |
Largecap Dividend Wisdomtree | DLN | Feb 28, 2025 | 81.91 | +1.44 |
Largecap ETF Vanguard | VV | Feb 28, 2025 | 273.71 | +1.73 |
Largecap Growth Opp Alphadex First Trust | FTC | Feb 28, 2025 | 141.20 | +1.43 |
Largecap Value Opp Alphadex First Trust | FTA | Feb 28, 2025 | 78.46 | +1.31 |
Largo | LGO | Feb 28, 2025 | 1.70 | +1.19 |
Larimar Therapeutics | LRMR | Feb 28, 2025 | 3.03 | +3.77 |
Las Vegas Sands | LVS | Feb 28, 2025 | 44.71 | +2.22 |
Laser Photonics | LASE | Feb 28, 2025 | 3.59 | +6.53 |
Latham Group | SWIM | Feb 28, 2025 | 5.91 | +0.51 |
Latin America Alphadex First Trust | FLN | Feb 28, 2025 | 16.50 | -1.37 |
Lattice Semiconductor | LSCC | Feb 28, 2025 | 62.34 | +2.94 |
Launch One Acquisition | LPAA | Feb 28, 2025 | 10.17 | +0.39 |
Launch One Acquisition | LPAAU | Feb 28, 2025 | 10.24 | 0.00 |
Launch Two Acquisition A | LPBB | Feb 28, 2025 | 10.06 | 0.00 |
Launch Two Acquisition Units | LPBBU | Feb 28, 2025 | 10.63 | +4.94 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.